๐Ÿ”Š CEOInterviews
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Alessandro Maselli

President, Chief Executive Officer & Director, Catalent

Search every verified Alessandro Maselli interview, podcast appearance, and on-the-record quote โ€” each transcript cross-checked by AI and human review to confirm speaker identity. On January 5, 2022, Catalent announced that its Board of Directors had appointed Alessandro Maselli, then President and Chief Operating Officer, to become the companyโ€™s next President and Chief Executive Officer, effective July 1, 2022. Maselli was also set to join the Board of Directors upon assuming the role. Outgoing CEO John Chiminski stated that the board had unanimously appointed Maselli, whom he described as an "outstanding leader" and "the perfect person to lead Catalen forward." Chiminski planned to remain as CEO until July 1, 2022, and then become Executive Chair of the Board. In remarks following the announcement, Maselli thanked Chiminski for his leadership and said the company had "great momentum and extraordinary foundations" to continue its track record of performance and growth. He attributed the companyโ€™s achievements to the "talent, commitment and dedication" of its employees and stated that the "recipe for success" would not change, emphasizing a strategy built on a "patient first" value and "excellence in quality and operations." Maselli said he would work with Chiminski to ensure business continuity until the leadership transition and expressed his commitment to making Catalent "a great place to work."

Selected quotes

Recent appearances

  • Catalent Senior Executives Announce Leadership Transition

    Catalent recently announced that its Board of Directors has appointed Alessandro Maselli, currently President and Chief Operating Officer, as the companyโ€™s next President and Chief Executive Officer, effective July 1, 2022. Maselli will also join the companyโ€™s Board of Directors upon assuming his new role. Current Chair and Chief Executive Officer John Chiminski will remain in his present role until July 1, 2022, when he will assume the position of Executive Chair of the Board. Catalent. More products. Better treatments. Reliably supplied.โ„ข Every molecule has a challenge. We have a soluโ€ฆ

    Watch on YouTube โ†—